NVOS (Novo Integrated Sciences) ROC %: -24.56% (As of May. 2024)


NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences ROC %?

Novo Integrated Sciences NVOS 12 ROC % is -24.56% as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Novo Integrated Sciences's annualized return on capital (ROC %) for the quarter that ended in May. 2024 was -24.56%.

As of today (2026-06-24), Novo Integrated Sciences's WACC % is 0.00%. Novo Integrated Sciences's ROC % is 0.00% (calculated using TTM income statement data). Novo Integrated Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Novo Integrated Sciences  (OTCPK:NVOS) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Novo Integrated Sciences's WACC % is 0.00%. Novo Integrated Sciences's ROC % is 0.00% (calculated using TTM income statement data). Novo Integrated Sciences earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Novo Integrated Sciences ROC % Related Terms

Novo Integrated Sciences ROC % Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences ROC % Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.46 -13.88 -9.64 -18.82 -21.55

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.46 -36.11 -37.82 -17.09 -24.56
NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novo Integrated Sciences ROC % Calculation

Novo Integrated Sciences's annualized Return on Capital (ROC %) for the fiscal year that ended in Aug. 2023 is calculated as:

ROC % (A: Aug. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Aug. 2022 ) + Invested Capital (A: Aug. 2023 ))/ count )
=-8.553 * ( 1 - 0% )/( (45.403 + 33.985)/ 2 )
=-8.553/39.694
=-21.55 %

where

Invested Capital(A: Aug. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=40.873 - 3.813 - ( 2.179 - max(0, 14.075 - 5.732+2.179))
=45.403

Invested Capital(A: Aug. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=35.563 - 5.095 - ( 0.416 - max(0, 7.905 - 4.388+0.416))
=33.985

Novo Integrated Sciences's annualized Return on Capital (ROC %) for the quarter that ended in May. 2024 is calculated as:

ROC % (Q: May. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Feb. 2024 ) + Invested Capital (Q: May. 2024 ))/ count )
=-10.08 * ( 1 - 0% )/( (35.909 + 46.164)/ 2 )
=-10.08/41.0365
=-24.56 %

where

Invested Capital(Q: Feb. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=34.949 - 3.98 - ( 0.652 - max(0, 9.959 - 5.019+0.652))
=35.909

Invested Capital(Q: May. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=35.327 - 5.678 - ( 1.54 - max(0, 22.676 - 6.161+1.54))
=46.164

Note: The Operating Income data used here is four times the quarterly (May. 2024) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -24.56% mean?
Novo Integrated Sciences (NVOS) has a ROC % of -24.56% as of May. 2024. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Novo Integrated Sciences and its competitors.
Is Novo Integrated Sciences' ROC % too high?
Novo Integrated Sciences' current ROC % is -24.56%. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' ROC % compare to BACK and NHLG?
Novo Integrated Sciences' ROC % of -24.56% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROC % is 3.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Healthcare Providers & Services company?
The median ROC % among Healthcare Providers & Services companies is 3.06, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Novo Integrated Sciences and its competitors. For the Healthcare Providers & Services industry, the median ROC % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novo Integrated Sciences's current ROC % is -24.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current ROC % of -24.56%. The current ROC % is -24.56%. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current ROC % is -24.56% as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price